Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06164028 · ClinicalTrials.gov registry record

COA-APTIC Cognitive Interview Study of Caregiver and Clinician Assessment of Acute Pain in Infants and Young Children

A clinical trial of Acute Pain, sponsored by Duke University.

Recruiting
Registry status
60
Enrollment target
1
Study location

NCT06164028 is a study of Acute Pain that is actively recruiting participants, run by Duke University. The registered enrollment target is 60 participants, below the 267-participant average among 50 other Acute Pain trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06164028, a study of Acute Pain, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
60 participants
Enrollment target
1
Study location

Study Summary

Evaluate the content validity and comprehensibility of a caregiver observer-reported outcome assessment and clinician-reported assessments for acute pain in children aged 0 to \<2 years. The primary objective of the Qualitative Protocol in the UH3 phase study is to establish or create reliable Clinical Outcome Assessments (COAs) and endpoints that can assess acute pain during clinical trials of pain therapeutics specifically designed for infants and young children (0 - \<2 years).

Conditions Studied

Interventions

  • OTHER cognitive interview

Study Locations (1)

North Carolina

  • Duke Clinical Research Institute - Durham

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-08-15
Est. Completion 2026-08-31

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT06164028

The ClinicalTrials.gov registry entry for NCT06164028 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 50 other Acute Pain trials with a reported enrollment target (78% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Pain appearing as the primary indexed condition, and to 1 intervention - of which cognitive interview is the first listed.

NCT06164028 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06164028 about?

NCT06164028 is a clinical study titled "COA-APTIC Cognitive Interview Study of Caregiver and Clinician Assessment of Acute Pain in Infants and Young Children". Evaluate the content validity and comprehensibility of a caregiver observer-reported outcome assessment and clinician-reported assessments for acute pain in children aged 0 to \<2 years. The primary objective of the Qualitative Protocol in the UH3 phase study is to establish or create reliable Clini...

What is the current status of trial NCT06164028?

This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2023-08-15. Estimated completion is 2026-08-31.

What conditions does trial NCT06164028 study?

This clinical trial studies the following conditions: Acute Pain.

What interventions are being tested in trial NCT06164028?

The interventions under investigation include: cognitive interview (OTHER).

Who is sponsoring clinical trial NCT06164028?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06164028 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.